Development of a Streptomyces venezuelae-Based Combinatorial Biosynthetic System for the Production of Glycosylated Derivatives of Doxorubicin and Its Biosynthetic Intermediates
Ah Reum Han,Je Won Park,Je Won Park,Mi Kyeong Lee,Yeon Hee Ban,Young Ji Yoo,Eunji Kim,Eunji Kim,Byung-Gee Kim,Jae Kyung Sohng,Yeo Joon Yoon +10 more
60
TL;DR: A range of doxorubicin analogs containing diverse deoxysugar moieties, seven of which are novel rhodomycin D derivatives, were generated and demonstrates the potential of the S. venezuelae-based combinatorial biosynthetic system for modifying structurally complex sugar moieties attached to anthracyclines as an alternative to chemical syntheses for improving anticancer agents.
read more
Abstract: Doxorubicin, one of the most widely used anticancer drugs, is composed of a tetracyclic polyketide aglycone and l-daunosamine as a deoxysugar moiety, which acts as an important determinant of its biological activity. This is exemplified by the fewer side effects of semisynthetic epirubicin (4'-epi-doxorubicin). An efficient combinatorial biosynthetic system that can convert the exogenous aglycone e-rhodomycinone into diverse glycosylated derivatives of doxorubicin or its biosynthetic intermediates, rhodomycin D and daunorubicin, was developed through the use of Streptomyces venezuelae mutants carrying plasmids that direct the biosynthesis of different nucleotide deoxysugars and their transfer onto aglycone, as well as the postglycosylation modifications. This system improved epirubicin production from e-rhodomycinone by selecting a substrate flexible glycosyltransferase, AknS, which was able to transfer the unnatural sugar donors and a TDP-4-ketohexose reductase, AvrE, which efficiently supported the biosynthesis of TDP-4-epi-l-daunosamine. Furthermore, a range of doxorubicin analogs containing diverse deoxysugar moieties, seven of which are novel rhodomycin D derivatives, were generated. This provides new insights into the functions of deoxysugar biosynthetic enzymes and demonstrates the potential of the S. venezuelae-based combinatorial biosynthetic system as a simple biological tool for modifying structurally complex sugar moieties attached to anthracyclines as an alternative to chemical syntheses for improving anticancer agents.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Metabolic engineering of Streptomyces peucetius for biosynthesis of N,N-dimethylated anthracyclines
Mandy B Hulst,Le Zhang,Helga U. van der Heul,Chao Du,Somayah S. Elsayed,Arina Koroleva,Thadée Grocholski,Dennis P. A. Wander,Mikko Metsä-Ketelä,Jacques J. C. Neefjes,Gilles P. van Wezel +10 more
TL;DR: The metabolic engineering of S. peucetius for biosynthesis of N,N-dimethylated anthracyclines successfully produced N,N-dimethyldaunorubicin, an anticancer drug with reduced cytotoxicity.
Biodiscovery of Actinomycetota through metabolo-genomics reveals functional diversity across contrasting Mexican ecosystems
Lorena Rodriguez-Orduña,Cesar Aguilar,Karina Verdel-Aranda,Augusto Vazquez Rodriguez,Jose L. Lopez-Ribot,Aldo Moreno Ulloa,Cuauhtemoc Licona Cassani +6 more
Abstract: Discovery of novel bioactive natural products from Actinomycetota has decreased, motivating the exploration of rare ecosystems. In this work, we integrated genomics and untargeted metabolomics to profile the biosynthetic capacity of Streptomyces and Nocardia strains isolated from two contrasting, Ramsar-listed Mexican biomes with well-defined ecological features: Cuatro Ciénegas, a semi-arid, oligotrophic karst basin with high microbial endemism, and Calakmul, a tropical rainforest characterized by high biodiversity, seasonal wetlands and limestone-derived alkaline soils. We hypothesized that bacteria isolated from contrasting environments would encode for novel and distinctive subsets of secondary metabolites. Using different metabolo-genomic approaches, a diverse collection of Streptomyces and Nocardia strains was identified, including several potentially novel species. Genome mining revealed a large repertoire of biosynthetic gene clusters (BGCs), many without matches to known metabolites, while molecular networking and dereplication (GNPS, SNAP-MS) exposed extensive chemical diversity within the isolates. Targeted synteny/ortholog analyses (CORASON) linked subsets of metabolites to BGCs, confirming actinomycin and collismycin and identifying komodoquinone-, nocardiopsistin- and rubiginone-like clusters. Notably, bioactivity assays of crude extracts demonstrated effective antifungal effects against Candida albicans SC5314 biofilms and planktonic growth, suggesting their potential therapeutic use. These findings reveal a significant untapped chemical space encoded by Actinomycetota from Ramsar sites, while reinforcing the need for improved tools to connect genomic and metabolomic data for natural product discovery.
A Streptomyces venezuelae Cell-Free Toolkit for Synthetic Biology.
Simon J. Moore,Simon J. Moore,Hung-En Lai,Soo-Mei Chee,Ming Toh,Seth Coode,Kameshwari Chengan,Patrick Capel,Christophe Corre,Emmanuel L. C. de los Santos,Paul S. Freemont +10 more
TL;DR: In this paper, a cell-free coupled transcription-translation (TX-TL) system was proposed to examine natural product biosynthetic pathways in a test tube, where the key advantages of this approach are the reduced experimental time scales and controlled reaction conditions.
In Vitro Reconstitution of the dTDP-l-Daunosamine Biosynthetic Pathway Provides Insights into Anthracycline Glycosylation.
TL;DR: In this paper, a reconstituted version of the enzyme in the daunorubicin/doxorubicain pathway was shown to be active in an in vitro system.
Genome-guided exploration of metabolic features of Streptomyces peucetius ATCC 27952: past, current, and prospect
Nguyen Huy Thuan,Dipesh Dhakal,Anaya Raj Pokhrel,Luan Luong Chu,Thi Thuy Van Pham,Anil Shrestha,Jae Kyung Sohng +6 more
TL;DR: This minireview summarizes the genome-based genome mining (GM) of diverse BCGs and genome exploration (GE) of versatile biocatalytic enzymes, and other enzymes involved in maintenance and regulation of metabolism of S. peucetius.
References
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
TL;DR: An overview of issues confirms that anthracyclines remain “evergreen” drugs with broad clinical indications but have still an improvable therapeutic index.
Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp.
M Bierman,R Logan,Kathryn A. O'Brien,Eugene Thomas Seno,Ramachandra Nagaraja Rao,Brigitte Elisabeth Schoner +5 more
TL;DR: It is shown that several of these vectors can be introduced into Streptomyces fradiae, a strain that is notoriously difficult to transform by PEG-mediated protoplast transformation.
1.5K
GDP-mannose 3',5'-epimerase forms GDP-L-gulose, a putative intermediate for the de novo biosynthesis of vitamin C in plants.
TL;DR: The plant epimerase undergoes a complex regulation and could control the carbon flux into the vitamin C pathway in response to the redox state of the cell, stress conditions, and GDP-sugar demand for the cell wall/glycoprotein biosynthesis.
405
A gene cluster for macrolide antibiotic biosynthesis in Streptomyces venezuelae: Architecture of metabolic diversity (polyketidesydeoxysugaryketolide)
Yongquan Xue,L Ishan Zhao,H Ung-Wen Liu,David H. Sherman +3 more
- 01 Jan 1998
TL;DR: In a survey of microbial systems capable of generating unusual metabolite structural variability, Strepto myces venezuelae ATCC 15439 is notable in its ability to produce two distinct groups of macrolide antibiotics as discussed by the authors.
291